BGI Genomics Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
3,752
- Stock Symbol
-
300676
- Investments
-
34
- Share Price
-
$5.43
- (As of Wednesday Closing)
BGI Genomics General Information
Description
BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.
Contact Information
Website
www.bgi.comCorporate Office
- Building 7, Huada Comprehensive Park
- 21 Hongan Third Street, Yantian District
- Shenzhen, Guangdong 518083
- China
Corporate Office
- Building 7, Huada Comprehensive Park
- 21 Hongan Third Street, Yantian District
- Shenzhen, Guangdong 518083
- China
BGI Genomics Stock Performance
As of 15-Jan-2025, BGI Genomics’s stock price is $5.43. Its current market cap is $2.26B with 416M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.43 | $5.48 | $4.59 - $8.10 | $2.26B | 416M | 4.34M | -$0.03 |
BGI Genomics Financials Summary
As of 30-Sep-2024, BGI Genomics has a trailing 12-month revenue of $562M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 2,260,804 | 2,201,958 | 2,141,218 | 4,590,364 |
| Revenue | 561,726 | 614,800 | 1,047,310 | 1,047,863 |
| EBITDA | (24,427) | 69,526 | 214,386 | 337,128 |
| Net Income | (14,157) | 13,131 | 119,201 | 226,346 |
| Total Assets | 1,894,440 | 1,920,409 | 2,084,995 | 2,236,242 |
| Total Debt | 118,004 | 154,672 | 137,147 | 136,517 |
BGI Genomics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BGI Genomics Comparisons
Industry
Financing
Details
BGI Genomics Competitors (24)
One of BGI Genomics’s 24 competitors is Novogene, a Formerly VC-backed company based in Beijing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novogene | Formerly VC-backed | Beijing, China | ||||
| Dante Labs | Venture Capital-Backed | New York, NY | ||||
| Ambry Genetics | Private Equity-Backed | Aliso Viejo, CA | ||||
| Metabiomics | Corporation | Carlsbad, CA | ||||
| Centrillion Technologies | Venture Capital-Backed | Palo Alto, CA |
BGI Genomics Patents
BGI Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023307866-A1 | Method and apparatus for detecting fetal chromosomal aneuploidy, and storage medium | Pending | 13-Jul-2022 | ||
| AU-2021474767-A1 | Sequence variation analysis method and system, and storage medium | Pending | 19-Nov-2021 | ||
| EP-4435791-A1 | Sequence variation analysis method and system, and storage medium | Pending | 19-Nov-2021 | ||
| EP-4152334-A1 | Gene sequencing analysis method and apparatus, and storage medium and computer device | Pending | 23-Jun-2021 | ||
| AU-2022298428-A1 | Gene sequencing analysis method and apparatus, and storage medium and computer device | Active | 23-Jun-2021 | G06F9/5027 |
BGI Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BGI Genomics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BGI Genomics Investments & Acquisitions (34)
BGI Genomics’s most recent deal was a Later Stage VC with Genolmmune Therapeutics. The deal was made on 28-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Genolmmune Therapeutics | 28-Dec-2022 | Later Stage VC | Biotechnology | ||
| Bamble | 14-Dec-2022 | Accelerator/Incubator | Business/Productivity Software | ||
| Genscreen | 05-Nov-2022 | Joint Venture | Other Healthcare | ||
| Hemu Gene Biotechnology | 15-Aug-2022 | Early Stage VC | Biotechnology | ||
| Genolmmune Therapeutics | 12-Aug-2022 | Later Stage VC | Biotechnology |
BGI Genomics ESG
Risk Overview
Risk Rating
Updated June, 07, 2024
19.45 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,104
Rank
Percentile
Pharmaceuticals
Industry
of 851
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 60
Rank
Percentile
BGI Genomics Exits (5)
BGI Genomics’s most recent exit was on 10-Dec-2018 from Baidao Medical. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Baidao Medical | 10-Dec-2018 | Completed |
|
||
| He Vision Group | 07-Dec-2017 | Completed |
|
||
| He Vision Group | 07-Dec-2017 | Completed |
|
||
| Gendi Healthcare | 23-Jun-2016 | Completed |
|
||
| PixieGene | Corporate | Completed |
|
Affiliates
Subsidiaries (6)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Hemu Gene Biotechnology | Shenzhen, China | 2018 | |
| Genolmmune Therapeutics | Wuhan, China | 2017 | |
| MGI Tech | Shenzhen, China | 2016 | |
| BGI Co-Win | Shenzhen, China | 2016 | |
| Complete Genomics | San Jose, CA | 2005 |
BGI Genomics FAQs
-
When was BGI Genomics founded?
BGI Genomics was founded in 1999.
-
Where is BGI Genomics headquartered?
BGI Genomics is headquartered in Shenzhen, China.
-
What is the size of BGI Genomics?
BGI Genomics has 3,752 total employees.
-
What industry is BGI Genomics in?
BGI Genomics’s primary industry is Laboratory Services (Healthcare).
-
Is BGI Genomics a private or public company?
BGI Genomics is a Public company.
-
What is BGI Genomics’s stock symbol?
The ticker symbol for BGI Genomics is 300676.
-
What is the current stock price of BGI Genomics?
As of 15-Jan-2025 the stock price of BGI Genomics is $5.43.
-
What is the current market cap of BGI Genomics?
The current market capitalization of BGI Genomics is $2.26B.
-
What is BGI Genomics’s current revenue?
The trailing twelve month revenue for BGI Genomics is $562M.
-
Who are BGI Genomics’s competitors?
Novogene, Dante Labs, Ambry Genetics, Metabiomics, and Centrillion Technologies are some of the 24 competitors of BGI Genomics.
-
What is BGI Genomics’s annual earnings per share (EPS)?
BGI Genomics’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
